App for home-based palliative cancer care maintains HRQoL, reduces hospitalizations

09 Nov 2026
Christina Lau
Christina LauManaging Editor; MIMS
Christina Lau
Christina Lau Managing Editor; MIMS
From left: Ms Yin-Ling Tai (head nurse of SUPPORT+), Dr Wendy Chan, and caregiver Ms ChanFrom left: Ms Yin-Ling Tai (head nurse of SUPPORT+), Dr Wendy Chan, and caregiver Ms Chan

SUPPORT+, an app for home-based palliative cancer care developed by researchers from the Department of Clinical Oncology, University of Hong Kong (HKU), is shown to better maintain health-related quality of life (HRQoL) and self-efficacy and reduce unplanned hospitalizations vs usual care in a randomized clinical trial (RCT) involving six palliative care clinics across Hong Kong.

The app integrates weekly symptom reporting (by patients or caregiver proxies using the Integrated Palliative Outcome Scale [IPOS]), automated symptom-specific self-management guidance, and nurse-led follow-up (including symptom assessment, red flag screening, and medication review) for severe symptom alerts. [JAMA Netw Open 2026;9:e2615509; https://support-plus.med.hku.hk/index.php]

In the multicentre RCT conducted between 25 January 2023 and 5 February 2025, 1,214 community-dwelling adults with advanced solid cancer who were no longer receiving systemic anticancer treatment (median age, 78 years; male, 50.8 percent) were randomized 1:1 to receive app-facilitated palliative care intervention plus usual care (n=590), or usual palliative care alone (n=624), and followed up for 18 weeks.

While participants in the usual care group also used the SUPPORT+ app, their access was limited to publicly available educational materials only. Caregivers were the majority of app users in both the intervention (71.4 percent) and usual care (64.1 percent) groups.

Digital symptom reports

In the intervention group, severe symptoms were reported in 36 percent of IPOS submissions. Pain was the most commonly reported severe symptom (12.3 percent), followed by weakness or lack of energy (8.5 percent), poor appetite (7.1 percent), and drowsiness (4.3 percent).

Over 18 weeks of follow-up, symptoms improved from severe to nonsevere in 21 percent of participants, and worsened from nonsevere to severe in 8.5 percent.

HRQoL & self-efficacy better maintained

At 18 weeks, the primary endpoint of HRQoL change, measured by EuroQol 5-dimension 5-level utility score, favoured the intervention vs usual care group (mean change, +0.03 vs -0.12; mean difference, -0.15; p<0.001). Self-rated health, measured by EQ visual analogue scale, showed a comparable pattern (mean change, +2.56 vs -4.18; mean difference, -6.09; p<0.001).

Self-efficacy, measured using the 6-item Self-Efficacy for Managing Chronic Disease Scale, was also better maintained in the intervention vs usual care group at 18 weeks (mean change, +0.05 vs -0.56; mean difference, -0.53; p<0.001).

Responder analyses showed higher odds of more positive outcomes in HRQoL and self-efficacy in the intervention vs usual care group.

Unplanned hospitalizations reduced

Fewer patients in the intervention vs usual care group had worsening unplanned hospitalization episodes (17.2 vs 28.5 percent; odds ratio [OR], 1.59; 95 percent confidence interval [CI], 1.21–2.10; p=0.001) or worsening inpatient days (18.5 vs 34 percent; OR, 1.84; 95 percent CI, 1.40–2.42; p<0.001). Mean inpatient days during follow-up were also fewer in the intervention group (8.9 vs 15.5 days).

However, emergency department utilization did not differ significantly between groups (20.2 vs 25.6 percent; OR, 1.27; 95 percent CI, 0.97–1.67; p=0.09).

Integration with routine palliative care

“Our study demonstrates that this patient-centered digital care model can strengthen community palliative care services, improve confidence in self-care, facilitate collaboration between healthcare and community care providers, and reduce avoidable hospital use,” said Dr Wendy Chan of the Department of Clinical Oncology, HKU, who led the study.

“The findings support integration of structured digital symptom monitoring with nurse-led follow-up into routine palliative care, and suggest that earlier introduction in the disease course may further enhance benefit,” the researchers concluded.